NYSEAMERICAN:XTNT - Xtant Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$6.00 -0.41 (-6.40 %)
(As of 05/22/2018 11:39 AM ET)
Previous Close$6.53
Today's Range$6.00 - $6.53
52-Week Range$3.96 - $14.52
Volume16 shs
Average Volume56,935 shs
Market Capitalization$140.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.19

About Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSEAMERICAN:XTNT
CUSIPN/A
Phone+1-406-3880480

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-43.03%
Return on EquityN/A
Return on Assets-25.99%

Miscellaneous

EmployeesN/A
Outstanding Shares13,080,000

Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Xtant Medical's stock reverse split on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) issued its earnings results on Tuesday, May, 9th. The medical device company reported ($3.46) EPS for the quarter, beating the Zacks' consensus estimate of ($3.54) by $0.08. The medical device company had revenue of $22.08 million for the quarter. View Xtant Medical's Earnings History.

What price target have analysts set for XTNT?

1 Wall Street analysts have issued twelve-month target prices for Xtant Medical's shares. Their forecasts range from $10.00 to $10.00. On average, they anticipate Xtant Medical's stock price to reach $10.00 in the next year. View Analyst Ratings for Xtant Medical.

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the folowing people:
  • Carl D. O'Connell, President, Chief Executive Officer (Age 53)
  • Darrel Lee Holmes, Chief Operating Officer (Age 62)
  • Gregory Juda Ph.D., Chief Scientific Officer (Age 39)
  • John K. Bakewell, Director (Age 55)
  • Michael Eggenberg, Director
  • Michael R. Mainelli Jr., Director (Age 55)
  • Robert E. McNamara, Director (Age 61)
  • Jeffrey J. Peters, Director

Has Xtant Medical been receiving favorable news coverage?

News headlines about XTNT stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Xtant Medical earned a daily sentiment score of 0.18 on Accern's scale. They also gave news stories about the medical device company an impact score of 45.49 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are Xtant Medical's major shareholders?

Xtant Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Park West Asset Management LLC (9.62%). View Institutional Ownership Trends for Xtant Medical.

Which institutional investors are buying Xtant Medical stock?

XTNT stock was purchased by a variety of institutional investors in the last quarter, including Park West Asset Management LLC. View Insider Buying and Selling for Xtant Medical.

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $6.00.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $140.58 million.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.


MarketBeat Community Rating for Xtant Medical (XTNT)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Xtant Medical and other stocks. Vote "Outperform" if you believe XTNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XTNT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Xtant Medical (NYSEAMERICAN:XTNT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Xtant Medical in the last 12 months. Their average twelve-month price target is $10.00, suggesting that the stock has a possible upside of 66.67%. The high price target for XTNT is $10.00 and the low price target for XTNT is $10.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.00$10.00$10.00$30.00
Price Target Upside: 66.67% upside107.04% upside107.04% upside303.23% upside

Xtant Medical (NYSEAMERICAN:XTNT) Consensus Price Target History

Price Target History for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN:XTNT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/14/2018Maxim GroupReiterated RatingBuy ➝ Buy$18.00 ➝ $10.00View Rating Details
11/30/2016AegisInitiated CoverageBuy$42.00View Rating Details
8/4/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Xtant Medical (NYSEAMERICAN:XTNT) Earnings History and Estimates Chart

Earnings by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN XTNT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/21/2017Q3 2017($5.64)$19.79 millionViewN/AView Earnings Details
8/9/2017Q2 2017($6.48)$21.41 millionViewN/AView Earnings Details
5/9/2017Q1 2017($3.54)($3.4560)$22.08 millionViewListenView Earnings Details
3/9/2017Q4 2016($3.60)($3.6840)$24.45 million$24.47 millionViewListenView Earnings Details
11/7/2016Q3 2016($3.84)($4.80)$22.80 million$23.09 millionViewN/AView Earnings Details
8/1/2016Q2 2016($4.80)($4.44)$22.25 million$21.46 millionViewN/AView Earnings Details
5/4/2016Q1($4.68)($5.28)$21.94 million$20.98 millionViewN/AView Earnings Details
3/15/2016Q415($2.64)$11.64$23.34 million$22.30 millionViewN/AView Earnings Details
11/11/2015Q3($1.80)($7.68)$19.64 million$17.69 millionViewListenView Earnings Details
8/12/2015($3.48)($4.92)$10.15 million$9.89 millionViewN/AView Earnings Details
5/5/2015Q1 2015($3.36)($6.60)$9.60 million$9.50 millionViewN/AView Earnings Details
3/17/2015Q414($4.20)($5.52)$8.90 million$9.10 millionViewN/AView Earnings Details
11/5/2014($2.76)($2.28)$8.45 millionViewN/AView Earnings Details
8/12/2014Q214($5.64)($4.20)$8.85 million$5.60 millionViewN/AView Earnings Details
5/6/2014Q114($0.48)($0.96)$9.73 million$8.90 millionViewN/AView Earnings Details
3/19/2014Q413($0.84)($0.96)$8.00 million$8.30 millionViewN/AView Earnings Details
11/7/2013Q3 2013($4.80)($9.60)$8.91 million$7.93 millionViewN/AView Earnings Details
8/6/2013Q2 2013($4.80)($7.20)$9.25 million$8.27 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.72)($0.48)$10.08 million$8.62 millionViewN/AView Earnings Details
3/26/2013Q4 2012($4.80)($13.20)ViewN/AView Earnings Details
11/7/2012Q312($0.48)($0.72)$9.29 million$8.90 millionViewN/AView Earnings Details
8/9/2012($0.60)$0.24ViewN/AView Earnings Details
5/3/2012($0.48)($0.36)ViewN/AView Earnings Details
3/22/2012Q4 2011($4.80)($9.96)ViewN/AView Earnings Details
11/10/2011Q3 2011($1.20)($5.64)ViewN/AView Earnings Details
8/11/2011Q2 2011($7.20)($1.20)ViewN/AView Earnings Details
5/12/2011Q1 2011($6.24)ViewN/AView Earnings Details
3/28/2011Q4 2010($10.32)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Xtant Medical (NYSEAMERICAN:XTNT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Xtant Medical (NYSEAMERICAN XTNT) Insider Trading and Institutional Ownership History

Insider Trading History for Xtant Medical (NYSEAMERICAN:XTNT)
Institutional Ownership by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN XTNT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/14/2018Orbimed Advisors LlcDirectorBuy945,819$7.20$6,809,896.80View SEC Filing  
5/9/2016Daniel S GoldbergerCEOBuy5,000$2.34$11,700.0015,510View SEC Filing  
12/3/2015Kent L. SwansonDirectorBuy3,300$2.83$9,339.0083,128View SEC Filing  
11/20/2015David Louis KirschmanEVPBuy2,000$2.99$5,980.001,701,063View SEC Filing  
11/20/2015Kent L. SwansonDirectorBuy5,000$3.00$15,000.0079,828View SEC Filing  
11/19/2015David Louis KirschmanEVPBuy2,000$2.90$5,800.001,699,063View SEC Filing  
11/16/2015Daniel S GoldbergerCEOBuy3,000$2.80$8,400.0015,510View SEC Filing  
9/4/2015Daniel S GoldbergerCEOBuy81,522$3.68$300,000.9612,510View SEC Filing  
9/4/2015Jon M WickwireDirectorBuy10,869$3.68$39,997.9231,247View SEC Filing  
5/22/2014Daniel S GoldbergerCEOBuy25,000$0.65$16,250.00View SEC Filing  
5/20/2014Gregory Alexander JudaInsiderBuy20,000$0.69$13,800.00View SEC Filing  
5/7/2014Guy S CookMajor ShareholderSell1,365,000$0.66$900,900.00View SEC Filing  
5/6/2014Guy S CookMajor ShareholderSell885,000$0.75$663,750.00View SEC Filing  
5/2/2014Guy S CookMajor ShareholderSell280,000$0.73$204,400.00View SEC Filing  
4/30/2014Guy S CookMajor ShareholderSell85,000$0.70$59,500.00View SEC Filing  
4/25/2014Guy S CookMajor ShareholderSell100,000$0.70$70,000.00View SEC Filing  
4/24/2014Guy S CookMajor ShareholderSell390,000$0.70$273,000.00View SEC Filing  
4/22/2014Guy S CookMajor ShareholderSell410,000$0.71$291,100.00View SEC Filing  
4/17/2014Guy S CookMajor ShareholderSell75,000$0.70$52,500.00View SEC Filing  
4/9/2014Guy S CookMajor ShareholderSell410,000$0.72$295,200.00View SEC Filing  
1/15/2014Guy S CookMajor ShareholderBuy160,000$0.64$102,400.00View SEC Filing  
1/7/2014Guy S CookMajor ShareholderSell273,300$0.53$144,849.00View SEC Filing  
12/26/2013Guy S CookMajor ShareholderSell64,380$0.53$34,121.40View SEC Filing  
12/24/2013Guy S CookMajor ShareholderSell300,000$0.44$132,000.00View SEC Filing  
12/11/2013Guy S CookMajor ShareholderSell160,000$0.42$67,200.00View SEC Filing  
11/19/2013Gregory Alexander JudaInsiderBuy20,000$0.45$9,000.00View SEC Filing  
11/12/2013Daniel S GoldbergerCEOBuy50,000$0.48$24,000.00View SEC Filing  
9/20/2013Guy S CookMajor ShareholderSell30,000$0.60$18,000.00View SEC Filing  
9/13/2013Darrel Lee HolmesCOOSell30,000$0.57$17,100.00View SEC Filing  
8/28/2013Guy S CookMajor ShareholderSell400,000$0.56$224,000.00View SEC Filing  
8/26/2013Daniel S GoldbergerCEOBuy20,000$0.60$12,000.00View SEC Filing  
8/19/2013Daniel S GoldbergerCEOBuy16,194$0.59$9,554.46View SEC Filing  
8/16/2013Daniel S GoldbergerCEOBuy13,806$0.58$8,007.48View SEC Filing  
6/18/2013Guy S CookMajor ShareholderSell372,859$0.52$193,886.68View SEC Filing  
6/13/2013Guy S CookMajor ShareholderSell175,000$0.55$96,250.00View SEC Filing  
6/13/2013Kent L SwansonDirectorBuy100,000$0.55$55,000.00View SEC Filing  
6/12/2013Guy S CookMajor ShareholderSell2,600$0.55$1,430.00View SEC Filing  
6/11/2013Guy S CookMajor ShareholderSell21,000$0.56$11,760.00View SEC Filing  
6/10/2013Guy S CookMajor ShareholderSell13,400$0.56$7,504.00View SEC Filing  
6/7/2013Guy S CookMajor ShareholderSell88,000$0.56$49,280.00View SEC Filing  
9/11/2012Guy S CookCEOBuy5,000$1.71$8,550.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Xtant Medical (NYSEAMERICAN XTNT) News Headlines

Source:
DateHeadline
Xtant Medical Holdings, Inc.: Xtant Medical Receives FDA 510(K) Clearance for InTice-C Porous Titanium Cervical Interbody SystemXtant Medical Holdings, Inc.: Xtant Medical Receives FDA 510(K) Clearance for InTice-C Porous Titanium Cervical Interbody System
www.finanznachrichten.de - May 21 at 9:30 AM
Xtant Medical Receives FDA 510(K) Clearance for InTice(TM)-C Porous Titanium Cervical Interbody SystemXtant Medical Receives FDA 510(K) Clearance for InTice(TM)-C Porous Titanium Cervical Interbody System
finance.yahoo.com - May 21 at 9:30 AM
Xtant Medical Holdings, Inc. 2018 Q1 - Results - Earnings Call SlidesXtant Medical Holdings, Inc. 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 11 at 10:44 AM
Edited Transcript of XTNT earnings conference call or presentation 9-May-18 1:00pm GMTEdited Transcript of XTNT earnings conference call or presentation 9-May-18 1:00pm GMT
finance.yahoo.com - May 10 at 9:56 AM
Xtants (XTNT) CEO Carl OConnell on Q1 2018 Results - Earnings Call TranscriptXtant's (XTNT) CEO Carl O'Connell on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 4:19 PM
Xtant Medical Announces First Quarter 2018 Financial ResultsXtant Medical Announces First Quarter 2018 Financial Results
finance.yahoo.com - May 9 at 9:45 AM
Xtant Medical to Issue First Quarter 2018 Results on May 8th, 2018Xtant Medical to Issue First Quarter 2018 Results on May 8th, 2018
finance.yahoo.com - May 3 at 9:34 AM
Xtant Medical Enhances Focus on International Growth with New PartnershipXtant Medical Enhances Focus on International Growth with New Partnership
www.baystreet.ca - April 19 at 9:44 AM
Xtant Medical Holdings (XTNT) Enters 3-Year Agreement with Healthcare International PartnersXtant Medical Holdings (XTNT) Enters 3-Year Agreement with Healthcare International Partners
www.streetinsider.com - April 19 at 9:44 AM
Xtant Medical Holdings, Inc. Announces Record Date for Proposed Rights OfferingXtant Medical Holdings, Inc. Announces Record Date for Proposed Rights Offering
www.baystreet.ca - April 18 at 9:44 AM
Form 4 Xtant Medical Holdings, For: Apr 08 Filed by: Mainelli MichaelForm 4 Xtant Medical Holdings, For: Apr 08 Filed by: Mainelli Michael
www.streetinsider.com - April 11 at 4:17 PM
What Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Share Price Doing?What Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Share Price Doing?
finance.yahoo.com - April 11 at 10:23 AM
Xtant Medical Holdings, Inc.: Xtant Announces Fourth Quarter and Year End 2017 Financial ResultsXtant Medical Holdings, Inc.: Xtant Announces Fourth Quarter and Year End 2017 Financial Results
www.finanznachrichten.de - April 3 at 10:02 AM
Xtant Medical to Issue Fourth Quarter and Full Year 2017 Financial Results Monday, April 2Xtant Medical to Issue Fourth Quarter and Full Year 2017 Financial Results Monday, April 2
finance.yahoo.com - March 27 at 10:10 AM
Xtant Medical Holdings Inc (XTNT) Short Interest UpdateXtant Medical Holdings Inc (XTNT) Short Interest Update
www.americanbankingnews.com - March 26 at 6:33 PM
Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 90.2%Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 90.2%
www.americanbankingnews.com - February 28 at 1:32 AM
Insider Buying: Xtant Medical Holdings Inc (XTNT) Director Purchases 945,819 Shares of StockInsider Buying: Xtant Medical Holdings Inc (XTNT) Director Purchases 945,819 Shares of Stock
www.americanbankingnews.com - February 23 at 9:22 PM
BRIEF-Xtant Medical Entered Twenty-Third Amendment To Amended Credit AgreementBRIEF-Xtant Medical Entered Twenty-Third Amendment To Amended Credit Agreement
www.reuters.com - February 17 at 9:10 AM
Xtant Medical regains compliance with NYSE American after converting debtXtant Medical regains compliance with NYSE American after converting debt
seekingalpha.com - February 17 at 9:10 AM
Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?
finance.yahoo.com - February 16 at 4:25 PM
Xtant Medical Holdings (XTNT) Reports Compliance with NYSE AmericanXtant Medical Holdings (XTNT) Reports Compliance with NYSE American
www.streetinsider.com - February 16 at 9:19 AM
Xtant Medical issues 10.4M shares of stock in convertible debt exchangeXtant Medical issues 10.4M shares of stock in convertible debt exchange
seekingalpha.com - February 15 at 4:24 PM
Maxim Group Reiterates Buy Rating for Xtant Medical (XTNT)Maxim Group Reiterates Buy Rating for Xtant Medical (XTNT)
www.americanbankingnews.com - February 14 at 6:00 PM
Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private PlacementXtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement
finance.yahoo.com - February 14 at 4:38 PM
Xtant Medical Holdings Inc (XTNT) Short Interest Down 5.1% in JanuaryXtant Medical Holdings Inc (XTNT) Short Interest Down 5.1% in January
www.americanbankingnews.com - January 25 at 1:32 AM
Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
finance.yahoo.com - January 22 at 5:39 PM
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible NotesXtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
finance.yahoo.com - January 18 at 11:02 AM
Before You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider ThisBefore You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider This
finance.yahoo.com - January 15 at 4:27 PM
Xtant Medical Holdings Inc (XTNT) Short Interest Down 6.3% in DecemberXtant Medical Holdings Inc (XTNT) Short Interest Down 6.3% in December
www.americanbankingnews.com - January 11 at 1:22 AM
What’s Ahead For Xtant Medical Holdings Inc (NYSEMKT:XTNT)?What’s Ahead For Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
finance.yahoo.com - January 6 at 4:24 PM
Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) CEO Pay Fair?Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) CEO Pay Fair?
finance.yahoo.com - December 29 at 4:23 PM
Xtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017Xtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
finance.yahoo.com - December 27 at 1:05 PM
At $0.5795, Is It Time To Buy Xtant Medical Holdings Inc (NYSEMKT:XTNT)?At $0.5795, Is It Time To Buy Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
finance.yahoo.com - December 14 at 4:57 PM
Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 1.0%Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 1.0%
www.americanbankingnews.com - November 28 at 1:04 AM
Maxim Group Reaffirms "Buy" Rating for Xtant Medical Holdings Inc (XTNT)Maxim Group Reaffirms "Buy" Rating for Xtant Medical Holdings Inc (XTNT)
www.americanbankingnews.com - November 23 at 3:18 PM
Xtant Medical Holdings Inc (XTNT) Sees Significant Drop in Short InterestXtant Medical Holdings Inc (XTNT) Sees Significant Drop in Short Interest
www.americanbankingnews.com - November 14 at 6:02 PM

SEC Filings

Xtant Medical (NYSEAMERICAN:XTNT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Xtant Medical (NYSEAMERICAN:XTNT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Xtant Medical (NYSEAMERICAN XTNT) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.